MX2022009375A - Formulacion para analogos anticolinergicos blandos. - Google Patents

Formulacion para analogos anticolinergicos blandos.

Info

Publication number
MX2022009375A
MX2022009375A MX2022009375A MX2022009375A MX2022009375A MX 2022009375 A MX2022009375 A MX 2022009375A MX 2022009375 A MX2022009375 A MX 2022009375A MX 2022009375 A MX2022009375 A MX 2022009375A MX 2022009375 A MX2022009375 A MX 2022009375A
Authority
MX
Mexico
Prior art keywords
formulation
soft
soft anticholinergic
hyperhidrosis
anticholinergic analogs
Prior art date
Application number
MX2022009375A
Other languages
English (en)
Inventor
Nicholas S Bodor
David Angulo
John J Koleng
Original Assignee
Bodor Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Laboratories Inc filed Critical Bodor Laboratories Inc
Publication of MX2022009375A publication Critical patent/MX2022009375A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las formulaciones tópicas que comprenden glicopirrolatos blandos son útiles para tratar afecciones de sudoración excesiva en sujetos, tales como humanos que sufren de hiperhidrosis. Preferiblemente, se proporciona al menos un agente anticolinérgico en una cantidad o concentración efectiva en una formulación anhidra que puede inhibir la transpiración excesiva que resulta de una afección tal como hiperhidrosis.
MX2022009375A 2016-07-21 2019-01-18 Formulacion para analogos anticolinergicos blandos. MX2022009375A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662365037P 2016-07-21 2016-07-21

Publications (1)

Publication Number Publication Date
MX2022009375A true MX2022009375A (es) 2022-09-02

Family

ID=60989819

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019000812A MX2019000812A (es) 2016-07-21 2017-07-20 Formulacion para analogos anticolinergicos blandos.
MX2022009375A MX2022009375A (es) 2016-07-21 2019-01-18 Formulacion para analogos anticolinergicos blandos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019000812A MX2019000812A (es) 2016-07-21 2017-07-20 Formulacion para analogos anticolinergicos blandos.

Country Status (17)

Country Link
US (5) US11123325B2 (es)
EP (2) EP3487475B1 (es)
AU (2) AU2017298469B2 (es)
BR (1) BR112019001081B1 (es)
CA (1) CA3031361C (es)
DK (1) DK3487475T3 (es)
ES (1) ES2954308T3 (es)
FI (1) FI3487475T3 (es)
HU (1) HUE062905T2 (es)
IL (2) IL295009A (es)
MX (2) MX2019000812A (es)
PH (1) PH12019500142A1 (es)
PL (1) PL3487475T3 (es)
PT (1) PT3487475T (es)
TW (2) TWI767507B (es)
WO (1) WO2018017852A1 (es)
ZA (1) ZA201901060B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105979969B (zh) 2013-08-08 2020-09-11 诺万公司 局部用组合物和使用所述组合物的方法
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
TWI767507B (zh) * 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
WO2020020879A1 (en) * 2018-07-24 2020-01-30 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Topical emulsion of an anticholinergic compound
US20230149349A1 (en) 2020-03-03 2023-05-18 Kaken Pharmaceutical Co., Ltd. Medicament containing sofpironium bromide
TW202146010A (zh) 2020-03-03 2021-12-16 日商科研製藥股份有限公司 原發性腋窩多汗症的治療方法及其醫藥

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US242A (en) 1837-06-22 moseley
US5292530A (en) 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US5232689A (en) 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
GB2280111B (en) * 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US5895644A (en) 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
JP4520682B2 (ja) * 1999-12-13 2010-08-11 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 臭気中和剤
US6319491B1 (en) * 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
AU2002340058A1 (en) 2001-09-26 2003-04-07 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US20060088496A1 (en) 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
EP1835812B1 (de) 2004-12-27 2011-08-17 Beiersdorf AG Glycopyrrolat in kosmetischen zubereitungen
JP2007058971A (ja) 2005-08-24 2007-03-08 Alpine Electronics Inc 情報再生装置
US7417147B2 (en) 2005-11-10 2008-08-26 Bodor Nicholas S Soft anticholinergic zwitterions
CA2627982C (en) 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
US8071693B2 (en) 2006-06-22 2011-12-06 Sabic Innovative Plastics Ip B.V. Polysiloxane/polyimide copolymers and blends thereof
JP5371235B2 (ja) 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
AU2008314628B2 (en) 2007-10-18 2014-03-06 Rose U Topical glycopyrrolate formulations
KR20210043742A (ko) 2013-03-15 2021-04-21 보도르 라보래토리즈, 인크. 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
AU2014297993A1 (en) 2013-07-30 2016-02-04 Glaxosmithkline Intellectual Property Development Limited Topical compositions for treatment of excessive sweating and methods of use thereof
US20150259283A1 (en) * 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
JP2017507959A (ja) 2014-03-13 2017-03-23 ボドール ラボラトリーズ， インコーポレイテッド 選択された抗コリン作動性両性イオンの使用
JP6647692B2 (ja) 2015-07-21 2020-02-14 ボドール ラボラトリーズ， インコーポレイテッド ソフト抗コリン類似体のための製剤
TWI767507B (zh) * 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Also Published As

Publication number Publication date
EP4218725A1 (en) 2023-08-02
EP3487475B1 (en) 2023-06-07
US11052067B2 (en) 2021-07-06
TWI767507B (zh) 2022-06-11
TW201803561A (zh) 2018-02-01
PT3487475T (pt) 2023-09-05
ES2954308T3 (es) 2023-11-21
AU2023202689A1 (en) 2023-05-18
US20200101044A1 (en) 2020-04-02
US20190247362A1 (en) 2019-08-15
MX2019000812A (es) 2019-06-20
AU2017298469A1 (en) 2019-02-21
US10959983B2 (en) 2021-03-30
EP3487475A4 (en) 2020-03-04
HUE062905T2 (hu) 2023-12-28
TWI719046B (zh) 2021-02-21
DK3487475T3 (da) 2023-09-11
TW202131913A (zh) 2021-09-01
AU2017298469B2 (en) 2023-02-02
US20180021300A1 (en) 2018-01-25
IL295009A (en) 2022-09-01
BR112019001081A2 (pt) 2019-04-30
WO2018017852A1 (en) 2018-01-25
IL264311A (en) 2019-02-28
US20210077459A1 (en) 2021-03-18
CA3031361C (en) 2024-02-27
IL264311B (en) 2022-08-01
US20220000839A1 (en) 2022-01-06
FI3487475T3 (fi) 2023-08-25
CA3031361A1 (en) 2018-01-25
US11123325B2 (en) 2021-09-21
BR112019001081B1 (pt) 2022-06-14
ZA201901060B (en) 2022-04-28
PL3487475T3 (pl) 2023-10-30
PH12019500142A1 (en) 2019-07-29
EP3487475A1 (en) 2019-05-29

Similar Documents

Publication Publication Date Title
PH12016501732A1 (en) Formulation for soft anticholinergic analogs
PH12018500184A1 (en) Formulation for soft anticholinergic analogs
PH12019500142A1 (en) Formulation for soft anticholinergic analogs
MX370963B (es) Composiciones para el cuidado personal.
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
MX2018000126A (es) Metodos para la administracion linfatica de agentes activos.
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
PH12017501133A1 (en) Pyrazolopyridinamines
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
MX2019013120A (es) Composicion que contiene dioxido de cloro y metodos para su uso.
PH12016500096A1 (en) Topical compositions for treatment of excessive sweating and methods of use thereof
GB2564990A (en) Topical compositions for neuropathic pain
ZA201801685B (en) Methods and compositions for soft anticholinergic esters
MX2018002176A (es) Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
MX2020012805A (es) Compuestos para el tratamiento del dolor, composiciones que comprenden los mismos, y metodos para utilizar los mismos.
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
MX2020005682A (es) Extracto de helichrysum gymnocephalum para el tratamiento y/o la prevencion de dermatosis inflamatorias.
WO2019025803A3 (en) ANTIMICROBIAL COMPOSITION
TN2017000517A1 (en) MULTl-PEPTIDE COMPOSITION